TELA Bio, Inc. (TELA) PT Lowered to $1 at Piper Sandler After '26 Rev Outlook Cut
Tweet Send to a Friend
Piper Sandler analyst Matt O'Brien lowered the price target on TELA Bio, Inc. (NASDAQ: TELA) to $1.00 (from $1.25) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
